Genomic Health
North America, California, United States, Redwood City
Description
Genomic Health is a provider of genomic-based diagnostic tests that address overtreatment and optimal treatment of early-stage cancer.
Investor Profile
Genomic Health has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E, Series D, Series F rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.
Stage Focus
- Series E (40%)
- Series D (20%)
- Series F (20%)
- Convertible Note (20%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Hospital
- Precision Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Genomic Health frequently co-invest with?
What are some of recent deals done by Genomic Health?
Find More Investors Like Genomic Health
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
